Korppi Matti, Heiskanen-Kosma Tarja, Kleemola Marjaana
Department of Pediatrics, Kuopio University and University Hospital, Kuopio, Finland.
Respirology. 2004 Mar;9(1):109-14. doi: 10.1111/j.1440-1843.2003.00522.x.
The objective of the present study was to assess the incidence of community-acquired pneumonia (CAP) in children caused by Mycoplasma pneumoniae.
During 12 months in 1981-1982, all CAP cases in a defined child population were registered. M. pneumoniae aetiology, initially measured by complement fixation (CF) test, was in 1999 supplemented by measurement of IgG and IgM antibodies using enzyme immunoassays (EIA).
M. pneumoniae was detected in 61 (30%) of 201 paediatric CAP cases, being the most common aetiological agent in those 5 years of age or over. At that age, M. pneumoniae was responsible for over 50% of cases, and over 90% of mycoplasmal cases were treated as outpatients. The EIA detected 17 new cases over and above the 44 detected by CF, while CF alone revealed 10 cases. The incidence of M. pneumoniae CAP increased with age, being over 10/1000 children at the age of 10 years or more. Co-infections with Streptococcus pneumoniae and Chlamydia pneumoniae were present in over 30% and 15%, respectively, of mycoplasmal CAP cases.
M. pneumoniae is a common cause of paediatric CAP in primary health care, and co-infections with S. pneumoniae are common. Both S. pneumoniae and M. pneumoniae should be taken into account when starting antibiotics for children with CAP.
本研究的目的是评估由肺炎支原体引起的儿童社区获得性肺炎(CAP)的发病率。
在1981 - 1982年的12个月期间,对特定儿童群体中的所有CAP病例进行登记。肺炎支原体病因最初通过补体结合(CF)试验测定,1999年补充了使用酶免疫测定法(EIA)检测IgG和IgM抗体。
在201例儿科CAP病例中,检测到61例(30%)由肺炎支原体引起,是5岁及以上儿童中最常见的病原体。在该年龄段,肺炎支原体导致超过50%的病例,超过90%的支原体病例作为门诊患者治疗。EIA检测出CF检测出的44例之外的17例新病例,而仅CF检测出10例。肺炎支原体CAP的发病率随年龄增加,10岁及以上儿童中发病率超过10/1000。分别超过30%和15%的支原体CAP病例合并感染肺炎链球菌和肺炎衣原体。
肺炎支原体是初级卫生保健中儿童CAP的常见病因,且常合并肺炎链球菌感染。在开始对CAP儿童使用抗生素时,应同时考虑肺炎链球菌和肺炎支原体。